A comparison of European and US generic drug markets

Category: Abstracted Scientific Content
Visits: 80 total, 1 today


Comparative research on the European and US generic drug markets based on 2013 IMS data across 13 European countries with different generic drug policies has recently been accepted for publication in the Milbank Quarterly [1], and abstracted here from a pre-print of the accepted article published on LSE Research Online [2].

Subscribe now to GaBI Journal to view full information of this article to be published in the next journal issue.

Go Back Print

Leave a Reply